Why pharma needs to embrace transparency now
Demands continue to mount for more visibility into how drugs are developed, priced, and distributed. Businesses that demonstrate transparency not only improve public trust but save money on noncompliance fines and fees.
So how are world-class organisations meeting legal and reputational requirements for full disclosure? One surprising answer may come from an unlikely department, presenting unexpected opportunities and rewards.